sPD‐L1 Expression is Associated with Immunosuppression and Infectious Complications in Patients with Acute Pancreatitis
Open Access
- 17 May 2017
- journal article
- research article
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 86 (2) , 100-106
Abstract
Acute pancreatitis (AP) with infectious complications has high mortality because of early‐stage immunosuppression. The programmed cell death‐1 (PD‐1)/programmed cell death ligand 1 (PD‐L1) pathway is an important host immunosuppression mechanism. Soluble PD‐L1 (sPD‐L1) expression regulates co‐inhibitory signals in malignancies or autoimmune disorders; however, its effects in AP are unknown. Here, we evaluated whether serum sPD‐L1 is involved in immune dysfunction and assessed its relationship with infectious complications in early AP. Blood samples were obtained from 56 patients with acute pancreatitis and 21 healthy individuals in this prospective study. Serum sPD‐L1 levels within 48 h after AP onset were tested by enzyme‐linked immunosorbent assays. Relevant immune parameters (human leucocyte antigen‐DR, lymphocyte count) and inflammatory markers (C‐reactive protein, white blood cell count) were analysed. sPD‐L1 was significantly upregulated in patients with early AP, especially those with infectious complications, compared to healthy controls. Significant negative correlations were observed among monocyte HLA‐DR expression, lymphocyte count and sPD‐L1 levels in AP. Multivariate regression indicated that sPD‐L1 was an independent risk factor for infectious complications in AP. The findings suggest that increased sPD‐L1 expression appears to be involved in the development of immunosuppression in the early stage of AP and that sPD‐L1 might be an early parameter for prediction of infectious complications in patients with AP.Keywords
Funding Information
- National Natural Science Foundation of China (81571931)
This publication has 34 references indexed in Scilit:
- Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapiesCurrent Opinion in Immunology, 2013
- Identification of a Soluble Form of B7-H1 That Retains Immunosuppressive Activity and Is Associated with Aggressive Renal Cell CarcinomaClinical Cancer Research, 2011
- Inflammation and immunosuppression in severe acute pancreatitisWorld Journal of Gastroenterology, 2010
- Infectious Complications in Patients with Severe Acute PancreatitisDigestive Diseases and Sciences, 2008
- PD-1 and Its Ligands in Tolerance and ImmunityAnnual Review of Immunology, 2008
- Immunosuppression in patients with severe acute pancreatitisJournal of Gastroenterology, 2006
- Long-term recurrence and death rates after acute pancreatitisScandinavian Journal of Gastroenterology, 2006
- Significance of apoptotic cell death in systemic complications with severe acute pancreatitisJournal of Gastroenterology, 2005
- Peripheral lymphocyte reduction in severe acute pancreatitis is caused by apoptotic cell deathJournal of Gastrointestinal Surgery, 2000
- APACHE IICritical Care Medicine, 1985